United States · FDA National Drug Code directory
Ceftriaxone Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-7337_c4d53472-41a6-428e-8935-f2c611729457
- Product NDC
- 0409-7337
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Ceftriaxone Sodium
- Labeler
- Hospira, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050509
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFTRIAXONE SODIUM — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-USE in 1 CARTON (0409-7337-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-7337-21) · 0409-7337-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →